By Author
  By Title
  By Keywords

September 2001, Volume 51, Issue 9

Review Articles


S. H. Ahmed  ( Department of Psychoses, Disorder to Disease, Institute of Behavioral Sciences, Karachi. )
U. Naeem  ( Department of Psychoses, Disorder to Disease, Institute of Behavioral Sciences, Karachi. )

It is more than one hundred years, in 1896 Emil Kraeplin divided the broad class of functional psychoses into two groups on the basis of eventual outcome. They were manic-depressive insanity and dementia praecox.
The predominant symptoms of manic depressive insanity were affective features, fluctuating course with frequent relapses and full recovery between episodes. Dementia praccox (the term first used by Morel in 1856) included catatonia described by Kahlbaum (1874), hebephrenia of Hecker (1871) and Kraeplin’s own dementia paranoides. The clinical syndrome represented a disease of brain, which pursued a steady down hill course to a state of chronic impairment of ‘intellectual’ functions or at best partial recovery. Kraeplin’s concept included weakening of emotional activities and loss of inner integration of cognition. emotion and volition- the intrapsychic ataxia1.
Then Eugene Bleuler under the influence of the powerful psychodynamic schools took us on a longer detour, enriching in many ways but riot without an apt comment by Roti and Harvey2 “to have forgotten that schizophrenia is a brain disease will go down as one of the great aberration of the 20th century medicine”.
lugene Bleuler published his dementia praecox or the group of schizophrenias in 1911. Bleuler disagreed with the cognitive arid intellectual impairment and considered them as associational defect and essentially the disorder was viewed as psychological rather than neuropathological. He renanìed dementia praecox as schizophrenia and divided the symptoms complex into Fundamental or primary and Accessory or secondary. The primary symptoms were disturbance of association (thought disorder, and loosening of association), affect. autism and ambivalence. The secondary sy mptoms were hallucinations and delusion3.
Bleuler’s emphasis on fundamental symptoms. not necessarily psychotic features. lead him to include his own sub-category. the simple schizophrenia. This then opened the gates to ‘include riiild arid latent’ cases to the limit of absurdity. To quote him ‘the simple schizophrenia vegetate as day labourers, peddlers and even as servants. They are also vagabonds arid hoboes On the higher level of society the most common type is wife who is unbearable, constantly scolding. nagging. always making demands, but never recogniziiig duties”4.
Kasanin5 in 1933 introduced the concept of schizo­affective disorder, to the relief of clinicians but further broadening the boundries of schizophrenia. Kurt Schnieder in 1959 produced a set of criteria he called First Rank symptoms (FRS) where hallucination and delusions (the Bleuler’s accessory symptoms) featured prominently. They were considered pathognomonic in the absence of disturbance of memory, orientation or delirium. The all important outcorne remained immaterial. While Europe (except Swiss group) remained orthodox, the United States under the influence of psychoanalytic schools. schizophrenia became the most favourite diagnosis, accommodating anything which did not fit anywhere. Then a time came when such diagnostic pattern was felt to “compromise treatment selection and still worse research efforts”.
New Diagnostic Criteria
Feighner et al in 19726 quietly developed a research criteria for the diagnosis of schizophrenia which required a six months duration of illness, objective signs and symptoms and specific inclusion arid exclusion criteria.
Soon two multinational studies in early seventies became a land mark in exposing the anarchy in the diagnosis of schizophrenia and paving the way to objectify the symptoms complex (rather than so called aetiological basis of DSM II). They were John Cooper’s (1972)7 Psychiatric Diagnosis in New York and London and WHO International Pilot Project on Schizophrenia (IPPS). This was followed by attempts at developing more objective tools like DSM Ill and IV of American Psychiatric Association and lCD 9 and 10 of World Health Organization.
Crow in 19808 basing his argument on molecular pathology and symptoms complex, postulated schizophrenia as more than one disease. It seems two syndromes can be distinguished - the first. Type I equivalent to ‘acute schizophrenia’ characterized by positive symptoms like delusion, hallucination and thought disorder. (seen in early years and settle down with neuroleptics); the second type II equivalent to ‘defect state and characterized by negative symptoms like affective flattening. poverty of speech arid cognitive deficits in pre-morbid development and less favourable response to neuroleptics.
Liddle9 has further subdivided schizophrenia into three categories and some evidence is available from functional imaging techniques (cerebral blood flow). They are: (I) reality distortion syndrome (abnormalities in medial temporal lobe): (2) dis-organization syndrome (dysfunction of right ventral prefrontal cortex) and (3) psychomotor poverty syndrome (dysfunction of left dorsal prefrontal cortex).
Neu roleptic Drugs and Neurotransmitter Research
In 1952 Delay and Denikar10 introduced chiorprornazine not as a super sedative but as a anti-psychotic. Soon after. neuroleptics found a place in psychiatric practice. It was suggested that the anti-psychotic properties of these drugs were related to their ability to induce extra pyramidal side effects11. The work of Hornykiew icz12 (1973) established that dopam me was depleted in the brains of patients who had parkinson’s disease. Carisson and Lindqvist in 196313 described selective effects of neuroleptic drugs on central dopamine turnover and attributed it to doparnine receptor blockade.
The discovery by Kebabian et al14 (1972) that dopamine rich areas of brain contained a dopamine stimulated adenylate cyclase allowed testing of the “dopamine hypothesis” in vitro. Phenothiazines and thioxanthenes blocks adenviate cyclase. But an important group of drugs. the butyrophenones (haloperidol) did not fit into this model. An alternative approach to the dopamine receptor is by the use of ligand-binding procedures. The receptor. which are assessed by this system, form a second and separate class of dopamine receptor D2. They are not linked to stimulation of adenylate cyclase activity.
Our understanding of dopaminergic function in the brain has been enhanced by molecular cloning of subtypes of dopamine receptor. The sub types include D1 and D2, together with three new receptors. In 1990. Sokoloft et al15 identified D3, Vantol et aI16 and Sunahara et al in 199117 identified D4 and D5 receptors.
In 1989 Carlsson18 maintained that dopamine hypothesis rest eventually on indirect evidence and even this is not satisfactory as anti-dopaminergic agents are not always efficacious in schizophrenia. Also that synitomatology is mimicked not only by dopamine agonist but also by PCP (phencyclidine) and anti glutarnatergic agents. Carlsson depleted dopamine by reserpine and the immobility thus achieved was dramatically reversed by systemic treatment with NMDA receptor antagonist. This still remains unexplained. It may be dopamine dysregulation rather than hyperdopaminergia. Their blockade could facilitates other activity.
Clozapine and risperidone have shown the place of serotonin (HT2) adrenergic (Al) and histarninergic (HI) activity. But the progress in this direction has not yet helped to understand the mechanism which produce the clinical picture.
Structural Basis
In recent years the hypothesis that schizophrenia is a brain disease has significantly gained ground. Structural imaging of the brain in life dates back to Dandy’s19 introduction of pneumoencephalography in 1919. in 1927 Jacobi and Winkler20 claimed that 18 of 19 schizophrenia patients showed ‘unquestionable’ internal hydrocephalus. But pneurnoencephalography is a procedure which can cause serious side effects in certain situation. In 1929 the American Roentgen Ray Society declared that it was unethical to use normal controls in pneumoencephalographic studies though the results were strongly supporting the view that was a biological basis for schizophrenia. The invention of computer-assisted tomography by Hounsfield21 in 1973 represented a major advance in the investigation of the structure of living brain.
A. Computer Assisted Tomography in Schizophrenia
A large number of CAT scan studies on brain have shown abnormalities in schizophrenia during the last two decades. The most robust findings of CAT studies are:
Venticular enlargement (lateral and third ventricles), cortical atrophy (increased sulcal markings) cerebellar vermin atrophy and reduction in cortical volume involving gray matter.
Lateral Ventricular Enlargement: The first study of CT scan abnormalities in schizophrenia was published by Johnstone et al in 1976 and 197822,23. They reported a significant enlargement in the area of lateral ventricles in a group of chronic institutionalized inale schizophrenics as compared with a group of age matched normal controls. Andreason et al24 noted that 36 out of 49 further studies which compared schizophrenic patients and controls under blind conditions found some increase in lateral ventricular size.
Since then niore than 90 controlled studies of ventricular size in schizophrenia have appeared in literature25-28. Ventricular dilatation has been demonstrated inpatients early in the course of the iIIness29,30. Most though not all studies have found a non-progression of ventricular size on follow up31-32. Taken together these results suggest that ventricular dilatation is present early in the course of illness and is static.
Third Ventricle Enlargenient: In a review and meta analysis of 23 studies Raz and Raz25 noted that in most studies, third ventricle enlargement was demonstrated despite the small size of the structure. In twin studies, Reveley et al (1982)33 compared ventricular size in series of identical twins who were discordant for schizophrenia using C.T. scans. Schizophrenic twins had larger ventricles than their co-twins in 6 out of 7 cases.
Pamnani and Ahmed34 and All35 in Pakistani samples of schizophrenics found statistically significant increase in VBR. Pamnani found that VBR in mixed schizophrenics group (with negative symptoms) was twice the size of controls than schizophrenics with positive symptoms. No difference was found on the basis of duration of illness or length or treatment.
B. Magnetic Resonance Imaging (M.R.l)
This structural imaging technique is superior to C.T. scanning in its ability to differentiate gray and white matter. With M.R.l.. visualization of temporal lobe and cortical sulci is much superior. Studies using M.R.l. have been carried out on schizophrenic patients since 1983.
In 1988, Crow36, confirmed increased size of lateral  entricles which became more prominent posteriorly. M.R.I. studies will be reviewed under three categories.
a) Assessment of whole brain size in schizophrenia: Several studies have found a reduction in brain area/volume in schizophrenic patients as compared to controls. The magnitude of this reduction is about 3-5%37-41, The overall decrease in cerebral volume was found to be more in the gray matter as compared to white42.
b) Twin Studies: Twin studies show that schizophrenic twins had larger ventricles that their co-twins33,43.
c) Temporal lobe Abnormalities: M.R.I. studies have been consistently demonstrating that schizophrenics show gross or localized changes of temporal lobe44. A few studies have reported significant reduction of left temporal areas as compared to the right side in schizophrenic patients45-49.
With M.R.I., it has been found that structural changes are even before the onset of disease and that it is non progressive. How ever, in a recent study by Jacobsen et al (1998)50 through anatomic brain magnetic resonance imaging scan have shown that progressive reduction of temporal structure occur with ongoing illness in childhood -onset schizophrenia. Also that it is right temporal involvement then the lefi.
C. Functional Imaging
A) Hypofrontality: Functional imaging was first applied to schizophrenia by Ingvar and Franzer in 197451. By using this techniques to measure regional cerebral blood flow. they found that schizophrenic patients had relatively lower activity in regions of frontal cortex that normal subject and now known as hypofrontality52. Functional neuroimaging studies of schizophrenia reports two forms of hypofronta i itv.
(1) Reduced prefrontal blood flow and metabolism in people with schizophrenia at rest53.
(2) Relative failure of activation of prefrontal cortex (relative to rest), when patients perform cognitive tasks.
a) Review of Positron Emission Tomography (PET) studies has largely supported the findings of hypofrontality in schozephrenic54.
b) Receptor Distribution: Basic research has provided strong evidence that the mechanism of action of neuroleptic agents is by blockade of the D2 dopamine receptors55. The D2 receptor occupancy ‘by neuroleptics is estimated by comparing the extent of reduction of radioactive D2 receptor ligand binding in the striatum of patients on neuroleptics as compared to drug free controls. Various investigators have demonstrated that patients on chronic neuroleptics show 65-80% receptor occupancy. This level of occupancy probably corresponds with clinical efficacy56,57. Atypical neuroleptics also show striatal receptor occupancies (does not spare striatal D2 receptors).
New Approaches: Through proton MRI studies it was possible to show that never treated schizophrenics show a significant increase in glutamine level in medical frontal cortex as compared to controls58. An interesting new technique called diffusion tensor imaging is used to study direct assessment of large axon masses stretching from prefrontal cortex to striatum59.
Other Significant Contribution
Genes: The causes of schizophrenic illness remains obscure. A genetic contribution is widely accepted60-62. Evidence from twin family with adoption studies argues persuasively that genetic features play a strong aetiological role in schizophrenia63,64. But the fact that the onset of symptoms is often in adult life and the concordance in monozygotic twins (about 50%) falls short of 100% suggest that genes may be relevant only in predisposing to some other factors.
Obstetric Complcations: Obstetric complications are increasingly recognized to represent an important somatic environmental factor associated with the later development of schizophrenia65,66. Many studies have shown that obstetric complications are commoner in early on set scizophrenia67,68. and in chronic schizophrenic subject than in controls69,70.
Acute, late onset and female schizophrenic subjects do not seem to share the excess of obstetric complications. This may be one reasons that all studies do not show an association with obstetric complications71. Four most recent studies72-75 suggest that the incidence of obstetrics complications is higher in people with schizophrenia but the magnitude is much less than the 2: 1 excess indicated by the earlier literature summarized by Geddies and Lawrie65.
Maternal influenza: One of the most consistent epidemiological findings in psychiatry has been that people with schizophrenia are more likely to be born in the late winter and spring months76. The more obvious explanation is exposure to viral infection in utero, for many viral infections are commoner in winter. Mednick et al77 examined the effect of the pandemic of ‘Asian flu which occurred in Helsinki in the autumn of 1957. It was seen that several months after the influenza epidemic (in spring 1958), there was 88% increase in the births of people who subsequently were diagnosed as schizophrenics. There is evidence in support of this from other studies namely 0’ Callaghan et al (1991). Kinugi et al(1992) and Adams et al (1993 )78-80.
Polio Virus: It has been suggested that pvenatal infection with polio virus, an entero virus, contributes to the development of schizophrenia because a decline in the incidence of schizophrenia occurred in many countries after the introduction of polio vaccination81,82,
Pre-morbid Abnormality: Neuro-developmental abnormalities in the pre-schizophrenic persons have repeatedly been described and is well established that early signs of the disorder can be found during infancy83.
(a) Deviancy as children: Higher proportion of male pre­schizophrenia children have had history of deviancy in childhood.
(b) Premorbid IQ deficit: is uncommon in pre­schizophrenic girls. but appears to be more pronounced characteristics of pre-schizophrenic boys.
(e) Abnormal Personality: Forester et al in 199184,85 have noticed personality problems and difficult social adjustment in 40% schizophrenics.
(d) Childhood characteristics: Jones et al (1994)86 examined 4746 children born during one week in 1946. Those who later became schizophrenic were slower to pass their developmental milestone that normal, were more likely to play alone at the age of four years and showed poorer performance on verbal and non verbal tests at the age of eight.
(e) Posture and Movement: Walker (1993)87 examined home movies of pre-schizophrenic children and compared it with movies of normal children. The pre-schizophrenics showed more postural and movements abnormalities of upper limbs, particulark during the first two years.
(f) Pruning process: Feinberg in 198388 pointed out that the normal process of’ pruning of cortical synapses continues throughout adolescence, and that an abnormality of pruning of dopamine synapses may be critical to the development of psychotic symptoms.
(g) Laterality: There is growing evidence that schizophrenia is associated with left side brain pathology. Flor Henry (1969)89 was the first one to suggest that temporal lobe epilepsy was more commonly associated when the focus was left sided. Several recent studies have suggested left side volume deficits of structures, such as planum temporale, which are thought to play a role in language90
(h) Birth weight and head circumference have been found to be significantly smaller in relation to the length. which is particularly evident in female pre-schizophrenic newborns73,74,91,92.
Social and Family Factors in Relapse
Brown and Birely in 196893 suggested that the recurrence of schizophrenia symptoms is preceded to an unexpected degree by the occurrence of life events three weeks before admission. Relapse was more likely where expressed emotions (EE) were high amongst the relation which includes over involvement, hostility and critical comments on the part of relatives94-98. Bateson et al (1956) originated the idea of ‘double bind’ which is a disordered family communication. Here conflicting parental messages are given through behaviour, attitude and feelings. This abnormal social interaction is postulated to be a contributing factor in schizophrenia99.
The change of term dementia praecox to schizophrenia, opened many new areas of observation and investigation. Type 1 and type II schizophrenia is a step further in the understanding of this complex disorder. In the wake of new tools and sophisticated methodology, is it time to change the term once again or break the unitary concept and identify different diseases? It may not be too far away.


1.lohnston EC Searching for the causes of schizophrema Oxford, OxfordUniversity Press.. 1994.P2.
2.Ron M. Harvey 1 the brain in schizophrenia 3. Neurol Neurosurg. Psychiatv 1990:53:725-26.
3.Ollerenshaw DP. Classification of functional Psychosis Br, J. Psychitry 1973:122.517-30.
4.Mervin K. Norquist GS Schizophrenia: epidemiology In Comprehensive text hook of psychiatry 5th ed. Baltimore: Williams. Wilkins. 989: Vol 1. pp.699­:705.
5.Kasanin J The acute schizoaffective psychoses. Am. J Psychiatry. 1933:90:97-126.
6.Fcighner JP. Robins E, Guze S. et al. Diagnostic criteria for use mpsychiatric research. Arch Gen Psychiatry., 1972.26 57-62.
7.Cooper JE, Kendell RE, Gurland Bi. et al. Psychiatric diagnosis in New York and London. Maudsley Monograph, No, 20, Oxford:Oxford University Press 1972.
8.Crow T.1. Molecular pathology of schizophrenia more than one disease process Br. Med   1980:280:66-68.
9.Liddle PE, Futson Ki, Erith CD. et al. Problems of cerebral blood flow in schizophrenia Br J. Psychiatry .1992.160 179-186.
10.Delav J, Deniker P Letraitment des psychosis par une method neurolytique derivee de Phibernotherapie. In (‘ongres de Medicines Alienistes et Neurologists de France Masson Editeurs Libraries de L Academic de Medicine. Paris and Luxembourg 1952.pp. 497-502.
11.Deniker P. Expenmental neurological svnchromes and the new drug therapies in psychiatry Comprehensive e Psychiairy., 1960:1 92-102.
12.Hornykiewiez 0. Dopamine in the basal gandlia: its role and therapeutic implications. Br. Med. Bull.. 1973.29 172-78.
13.Carlsson A. Lindqvist NI Hkct of clilorproinazine and haloperidol on formation of 3-methoxy -tyramine and normetanephrine in mouse brain Aeta. Pharmacol :1 Toxico.. 1963.20: 140-44.
14.Kebabian JW, Peizold, GL. (ireengard P. Dopamine sensitive adenylate cyelase in caudate nucleus of rat brain and is similarly to the dopainine receptor Proce Nat. Acad. Sci. USA.. 1972:69 2145-2149.
15.Sokoloff P. Giros B. Martres MP et al. Molecular cloning and characterization of a nov cl dopamine receptor D3 ) as a target for neurokpi es Nature 1990:374 146-51.
16.Van Tol. HHM. et al, Cloning of the gene for a human dopamine D4 receptor with ugh affinity for the antipsychotic clozapine Nature., 1991:350-610-14.
17.Sunahara RK Cloning of the gene for a human dopaminç D5 receptor W ith high affinity for dopamine than 1)1 Nature.. 1991.350 614-19.
18.Carlsson A. The current status of the dopamine hypothesis of schizophrenia Neuropsychopharmacoiogy 1988:1 179-86.
19.Dandy WE Roenmgenographv of the brain after injection of air into the cerebral ventricles. Am. J. Reontgenographs.. 19 19:6 26.
20.Jacobi W. Winkler H Encephaiographische Studien an chronisch schizophrenen Arch Fur Psychiatric Nervenkrank 1972:81.299-332.
21.H ounsfield GN. Coinputerused transserse axial scanning (tomography). Pt 1 Description of the system Br J, Radiology.. 1973.46 1016-1022.
22.Jphnstone EC Crow TJ. Filth CD et al Cerebral ventricular size and cognitive impaiment in chronic schizophrenia Laneet., 1 976.ii:924-26.
23.Johnstone EC. Crow Ti. Fifth CD et al The demetutia of dementia praecox. Acta Psychiatr Scand , 978.57:305-324.
24.Andreasen NC. Swayze VW. Flaum Ni. et al Ventncular enlargement in schizophrenia. Evaluated w ith computed totnographic scanning: effects of gender. age and stage of illness, Arch, GEN. Psychiatry.. 1990:47:1008-1015.
25.Raz S. Raz N Structural brain abnormaIities in the major psy choses; a quantitative ve rev iew of the evidence front computerized imag ing Psychol Bull.. 1990.108 93-108.
26.Van Hom JD. and MeManus IC Ventricular enlargement in schizophrenia’ a meta-analvsis of studies of the brain ration (I VBR). Br. J Psychiatry 1992:1 60:687-97.
27.Lewis SW Comnputertsed tomography in schizophrenia 15 years on Br J Psychiatry 1990: 157 ( Suppl 9). 16-24.
28.Ward KE. Friedman L Wise A. et al. Meta analysis of brain and cranial size in schizophrenia Schizophrenia Research.. 1996.22 197-2 3.
29.L ewis SW A controlled quantitatve study of computed x-ray tomography in functional psschoses MD thesis, tints ersity of London., 993.
30.Weinberger DR. Cannon-pour E, Potkin al. Poor premorbud adjustment and CT scan abnormalities in chronic schizophrenia Am J Psy ch,atrv.180. 132 410-1413.
31.Illow sky BP. Juliano AM. Bigelaw LB. et al, Stability of CT Sean hindings in schizophrenia: result of an eight vear follow up study J. Neurol. Neurosurg Psy chiatry . 1988.51 .209-13.
32.Nastallah Ha. Olson SC. Me Calley -Whitters Ni, et al. Cerebral ventricular size in schizophremia a preliminary follow up studs Arch. Gen Psychiatry 1986.43 157-59.
33.Reveler AM Ret eley M.y. Clifford CA ci al. Cerebral ventricular size in twins discordant for schizophrenia Lancet . 1 982;1 .540-41.
34.Pamnani Kl I. Abutted Sh, Cerebral ventricular culargement in schizophrenia p roceeding Seventh Internati tonal Psychi atrie Conference. Pakistan Psy chiatric society 988. Karachi. 129-33.
35.Alt Z C.J scan changes in seluzophrenia FCPS dissertation. 995.
36.Crow TI. Colter N. Brown] R. ct al Lateralused ass mmetry of temporal hom enlargement in schizophrenia Schizophr Res. 1988:1. I 55-56.
37.Anderson NC. Nasrallali HA Dunn V et al. Structured abnormalities in the frontal system inschizophrenia Arch Gen Psychiatry . 986.43.1.
38.Johnsione EC. Crow Ti. em al. Thie spectrum ofhratn changes in schizophrenia age ot onset as a predictor of cognitive amid clinical impairment and their cerebral correlates. Psychol Med.. 1986:19 91-103.
39.Nasrallah HA. Coffman JA. em al. Reduced cerebral volume in schizophrenia Schizoph Res., 199(1:3’ 17.
40.Kehsoe J. Cadet JL Pickar D. ci al Quantitative neuroanatomy in schizophrenia Arch Gen. Psychiatry 1988.4 5:533-41.
41.Harvev I, Ron NI. Du Boulay (i. et al Diffuse reduction of cortical volume in schizophrenia on magnetic resource imaging Psychol Med.. 1993:23 591­:604.
42.Lipurskv RB. k(.). Suillivan EV. em al. Widespread cerebral gray matter volume deficits in schizophrenia Arch. Gen Psvchiatr , 1992.49.195-205.
43.Suddath RE. Chnstmson GW. ci al. Anatomical abnormalities in the brain of monozygotic tw ins discordant for schizophrenia N. EngI. J. Med.. 1990:322:789-94.
44.Wright IC, Rabe-Heskth S. Woodruff PW em al Mcia-anahvsis of reginal brain volumes in schizophrenia. Am. j. Psychiatry.. 2000:157:1. 16-25.
45.Bogerts B. Ashtari NI. Degreef G. ci al Reduced temporal limbic structure volumes out magnetic resonance images in first episode schizophrenia Psychiatry Res. Neuroimagign . 1990a.35 1-13.
46.Johnstone EC. Owens DGC Crow TI. et al. Temporal lobe structure as determined by nuclear magncttc resonance in schizophrenia amid bipolar affective disorder. I Neurol. Neurosurg Psychiatry . 1989.52;776-41.
47.Coffman JA, Schwarzkopf SB. et al. Temporal lobe asymmetry in schizophrenics demonstrated by coronal MRI brain scan Schizophrema Researcht . 1989:2:117.
48,Shenton ME, Ktkunts R, jolesz FA, em al. Abnormalities of the temporal lobe and thought disorder in schizophrenia: a quantitative c magnetic resonance imaging. N Engl J Med . 1992:327:604-12.
49.Zipursky RB. Marsh L. Liutu KO. em al Volumetric MRI assessment of temporal lobe structures in schizophrenia Biolog cal Psychiatry 994:35:501-16.
50.Jacobsen LK. Giedd JN. Castellanos EN. em al. Ant I Psychiatry . 1998:155:5. 678.85.
51.lngvar DV, Franzen ( Abnormalities of cerebral blood flow dustrihumuomu mu patients with chronic schizophrenia. Acta. Psychiatr. Scand . 974.50 452-62.
52.Gtmr RC. Gur RE. H ypofrontalitv in schizophrenia. Lancet.. 1995:345 1383­:85.
53.Sabri 0. Erkwob R. Schrekenberger M. ci al. Correlaticun of positive symptoms exelusiv ely to hyperfusion or hypoperfusion if cerebral cortex in ties er treated scbizophrentcs. Facet.. 1997.349:1735-39.
54.Fiddle PF, H erold S. Fletcter P. ci al. A PET studs of word generation in schizophreiita. Schizophrenia Research - 1994:11:168.
55.Seetnami P Dopamine receptors and the dopamnine hypothesis of schizophrenia Synapse. 1987:1 133-52.
56.Farde L, Weisel FA. ci al Central D2-dopamine receptor occupancy in schizophrenic pafients treated with antipsy ehoimc drugs. Arch. Gen Psychiatry . 1988:45 71-76.
57.WOLKIN a. baurouche F. ci al. Dopaumine blockade and clinical response. evidence for two brological subgroups of schizophrenia Am i Psychiatry - 1989.1 46.905-8.
58.Baitha K. Williamson PC.Dorsei DJ, et al Measurement oh glutainate and glutamine in mite medical pre-frontal cortex of never treated schizophrenic patients and healthy controls by proton magnetce lesonance spectroscopy Arch (ien Pus chutry 1997;54 959-65.
59.Buchsbaum MS  ang CY. Peled S. ci al. MRI white matter diffusion anisotropy and PET metablie rate in sehizophrenia Neuro Report.. 1998:9:425-30.
60.Murray RM. Reveley .\\\\M. Meguffin P Genetic vulnerability to schizophrenia In Sehizophrenia. Psy chiatric Clinics of North America - 1986.9:3-16.
61.Mcguffin P. Murra R Ni, Reveley AM. Genetie influences on the functional psychosis Br Med, Bulletin. , 1987.13;531-56.
62.Cardno AG. Marshall Ej, Coid B. em al H eritability cut miates for psychotic disorders. Arch (.jen Psy chuiatry., 1999 162-68.
63.Gottesman II Schizophrenia Genesis The of igins of madness. Ness York. Freeman 1991.
64.Kendkr KS. Schizophremia genelics comprehensive lest book of Psychiatry 7th ed. vol. 1. Baltimore: Williams and Wilkins, 1999;pp.1147-59.
65.Geddes JR. Lawrie SM Obstetric complications and schizophrenia: a meta analysis Br. J. Psychiatry., 1995:167.786-93.
66.McNeil TF. Pennatal risk factors and schizophrenia: selective review and methodological concerns. Epidemiol. Rev., 1995:17:107-12.
67.O’Callaghan F. Gibson T, colohan HI, et al. Risk of schizophrenia in adults born after obstetric complication and their association with early of illness: a controlled study Br. Med. J., 1992:305:1256-59.
68.Owen MJ, Lewis SW. Murray RM, Obstetric complication and schizophrenia. Psychol Med., 1988;18:331-39.
69.Murray RM, Lewis SW, Owen Mi. et al. The neurodevelopmental origins of dementia praecox. In’ schizophrenia: the major issues. London Heinemann. 1 980:pp.90- 107.
70.Less is SW. Owen Mi. Murray RM. Obstetric complications and schizophrenia: methodology and mechanisms. In Schizophrenia: scientific progress. New York Oxford University Press.. 1989:pp.56-68.
71.Done DJ, Johnstone EC, Frills CD, et al. Complications of pregnancy and deliverv in relaimon to psychosis in adult life. Br. Med. J., 1991:302:1576-80.
72.Dalman C. Allebeck P. Cullberg J, ct al, Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch. Gen. Psychiatry., 1999.56 234-40.
73.Hultman CM, Sparen P, Takei N. et al. Prenatal and pennatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case control studs. Br. Med J., 1999.3 18:421-26.
74.Jones PB. Rantakallio P. Hartikainen A, et al. Schizophrenia as a long-term outcome of pregnancy. deliv ery and perinatal complications: a 28 year follow­up of the 1966 North Finland general population birth cohort. Am. J. Psychiatry., 1998:155:355-64.
75.Kendell RE, McInneny K. Juszcaek E. et at, Obstetric complications and schizophrenia’ two case control studies based on structured obstetric records Br J Psychiatry . 2000:176:516-22.
76.Hare E. Temporal factors and trends, including birth seasonality and the viral hypothesis In: Handbook of Schizophrema. V.3. Amsterdam. Elsevier., 1988:pp. 345-77.
77.Mednick SA. Machon RA. Huttenen MO. et al. Adult schizophrenia following prenantal exposure to an influenza epidemic. Arch. Gen. Psychiatry., 1988.45 189-92,
78.O’Callaghan E. Sham P, Takei N, et al. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet., 1991:337:1248-50.
79.Kinugi It. Nanko S. Takei N. Influenza and schizophrenia in Japan. Br. J. Psychiatry., 1992:161.274-75.
80.Adams W, Kendell RE, Hare EH, et at. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. Br J. Psychiatry. 1993:163:522-34.
81.Eagles JM. Are Polmovirus a cause of schizophrenia? Br. J. Psychiatry., 1992:160:598-600.
82.Squires RF. How a polio virus might cause Schizophrenia: a eommentary on Eagle’s hypothesis. Nestrochem Res.. 1997:22:647-56.
83.Jones P. Done DJ. From birth to onset: a developmental perspective of schizophrenia in two national birth chorts in neurodevelopment and adult psychopathology. New York: CUP.. 1997:pp 119-36.
84.Foerster A, Lewis S. Owen M, et at. Premorbid personaliy in psychosis: effects ofsex and diagnosis. Br. J. Psychiatry. 1991:158 171-76.
85.Foerster A, Lewis s. Owen M, et al. Low birth weight and a family history of schizophrenia redict poor premorbid functioning in psychosis. Sehizophenia Research , 1991b:5:3-20.
86.Jones P. Murray RM, Rodgers B Child development preceding adult schizophrenia. Schizophrenia Research 1994:11:97.
87.Walker E. Neurodevelopment aspects of schizophrenia. Schizophrenia Research., 1993:9:151-52. ­
88.Femberg 1. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence J Psschiatr Res, 1983:17:319-34.
89,Flor-Henrv P. Psychosis and temporal lobe epilepsy Epilepsia.. 1969:10:363­:65.
90.McGuire PK, Shah GMS. Murray RM. Increased blood flow in Broca’s area during auditory hallucinations inschizophrenia. Lancet.. 1993.342 703-6.
91.McNeil TF. Cantor-Grane E, Nordstorn LG, et al. Head circumference in “pre schizophrenic. And control neonates. Br. J. Psychiatry., 1993:162: 517-23.
92..Kunugi H, Takei N, Murray RM et al Small head circumference at birth inschizophrenia. Schizophrenia Research., 1996:20: 165-70.
93.Brown GW. Birlcv JLT. Crises and life changes and the onset of schizophrenia. i. Health and Human Behavior., 1968:9:203-14.
94.Kavanagh Di. Recent developments in expressed emotion and schizophrenia. Br. J, Psychiatry . 1992,160:601-20.
95.Hooley JM. Expressed emotion: a review of the eritieal literature. Clinical Psychology Rev., 1985:5:119-39.
96.LeffJP, Wig NN. Ghosh H, et al. The influence of relatives expressed emotion on the cause of schizophrenia in Chandigarh. Br. J. Psychiatry.. 1987:151.166­.
97.LeffJP, Kuipers L, Berkowitz R. et at. A controlled trial of social intervention in the famities of schizophrenic patients Br. J. Psychiatry . 1982.14 1:121-34.
98.Parker G, Ftadzi-Pavlovic D. Expressed emotion as a predictor of schizophrenic relapse: an analysis aggregation of data. Psychol Med.,1990;20:95 1-65.
99.Bateson G, Jackson DD. Haley J, et al. Towards a theory of schizophrenia. Behavioral Science., 1956:1251-64.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: